Home » Topics » Regulatory » Patents

Patents
RSS

Shenzhen Targetrx Biotechnology divulges novel ALK inhibitors

Sep. 26, 2017

Bill & Melinda Gates Foundation and Anacor patent boron-containing small molecules

Sep. 26, 2017

Otsuka divulges novel compounds for brain cancer

Sep. 22, 2017

Bayer discovers new BUB1 inhibitors

Sep. 22, 2017

Bill & Melinda Gates Foundation, Anacor present boron-containing pleuromutilins

Sep. 22, 2017

Novel PI4KII-BETA inhibitors discovered at Stanford, UC Oakland

Sep. 22, 2017

The University of Szeged identifies new alpha-7 nicotinic receptor agonists

Sep. 21, 2017

INSERM and collaborators describe antibodies targeting B- and T-lymphocyte attenuator

Sep. 21, 2017

Nationwide Children's Hospital patents gene therapy targeting DUX4

Sep. 21, 2017

Asahi Glass describes novel influenza vaccines

Sep. 21, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...